These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 1183732

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Glucagon regulation of plasma ketone body concentration in human diabetes.
    Schade DS, Eaton RP.
    J Clin Invest; 1975 Nov; 56(5):1340-4. PubMed ID: 1184755
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man.
    Miles JM, Haymond MW, Nissen SL, Gerich JE.
    J Clin Invest; 1983 Jun; 71(6):1554-61. PubMed ID: 6134753
    [Abstract] [Full Text] [Related]

  • 6. The role of glucagon in the regulation of plasma lipids.
    Schade DS, Woodside W, Eaton RP.
    Metabolism; 1979 Aug; 28(8):874-86. PubMed ID: 378241
    [Abstract] [Full Text] [Related]

  • 7. The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man.
    Schade DS, Eaton RP.
    Horm Metab Res; 1977 Jul; 9(4):253-7. PubMed ID: 892688
    [Abstract] [Full Text] [Related]

  • 8. Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics.
    Schade DS, Eaton RP.
    Diabetes; 1975 May; 24(5):510-5. PubMed ID: 805077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise.
    Wahren J, Sato Y, Ostman J, Hagenfeldt L, Felig P.
    J Clin Invest; 1984 May; 73(5):1367-76. PubMed ID: 6715541
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Experimental hyperosmolar diabetic syndrome. Ketogenic response to medium-chain triglycerides.
    Gordon EE, Duga J.
    Diabetes; 1975 Mar; 24(3):301-6. PubMed ID: 123210
    [Abstract] [Full Text] [Related]

  • 14. The effect of diazoxide-induced hormonal secretion on plasma triglyceride concentration in the rat.
    Eaton RP, Schade DS.
    Diabetologia; 1980 Apr; 18(4):301-6. PubMed ID: 6998802
    [Abstract] [Full Text] [Related]

  • 15. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man.
    Schade DS, Eaton RP, Peake GT.
    Diabetes; 1978 Sep; 27(9):916-24. PubMed ID: 689302
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of ketone body infusion on plasma growth hormone and glucagon in man.
    Quabbe HJ, Trompke M, Luyckx AS.
    J Clin Endocrinol Metab; 1983 Sep; 57(3):613-8. PubMed ID: 6348066
    [Abstract] [Full Text] [Related]

  • 18. Role of glucagon in enhancing ketone body production in ketotic diabetic man.
    Keller U, Schnell H, Sonnenberg GE, Gerber PP, Stauffacher W.
    Diabetes; 1983 May; 32(5):387-91. PubMed ID: 6132846
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.